Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novus Biologicals LLC

Division of Bio-Techne Corp.
www.novusbio.com

Latest From Novus Biologicals LLC

Janssen's Zytiga Shines At ASCO But Prostate Cancer Pipeline Progress May Dampen Impact

Janssen reported treatment altering Phase III data at ASCO 2017 for a new Zytiga combination targeting hormone-naïve metastatic prostate cancer patients – but the triple regimen's relevance might be short-lived as momentum builds in the late-stage pipeline.

Clinical Trials Cancer
See All

Company Information

  • Industry
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Bio-Techne Corp.
  • Senior Management
  • Karen Padgett, CEO
    Todd Padgett, CFO
    Dave Eansor, SVP, Corp. Dev.
  • Contact Info
  • Novus Biologicals LLC
    Phone: (303) 730-1950
    8100 Southpark Way
    A-8
    Littleton, CO 80120
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register